EGFR-HER2 inhibitor Lazertinib, Purity ≥98%

Cat. No.: X24-05-ZQ667

EGFR-HER2 inhibitor Lazertinib, Purity ≥98%

Synonym: 1903008-80-9; YH 25448; YH-25448; GNS1480; GNS 1480; EGFR-HER2 inhibitor

  • CAS Number: 1903008-80-9
  • Compound CID: 121269225
Product Size
5 mg; 10 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
Lazertinib, soluble in DMSO and insoluble in ethanol and water, is a compound that blocks the activity of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER2), both of which are involved in driving the growth and proliferation of certain types of cancer cells. It targets EGFRT790M.
Molecular Weight
554.66
Molecular Formula
C30H34N8O3
Targets
EGFRT790M
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 4 mg/mL (7.21 mM); Water: Insoluble; Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
Lazertinib can be utilized to study its use as a third-generation EGFR inhibitor in non-small cell lung cancer.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.